Neuberg Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 139.15 Cr
as on 04-07-2024
- Paid Up Capital ₹ 94.49 Cr
as on 04-07-2024
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 561.12 Cr
as on 04-07-2024
- Revenue 219.36%
(FY 2023)
- Profit -712.32%
(FY 2023)
- Ebitda -5724.72%
(FY 2023)
- Net Worth 1861.64%
(FY 2023)
- Total Assets 70.79%
(FY 2023)
About Neuberg Diagnostics
The Corporate was formerly known as Sylaan Enterprises Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 139.15 Cr and a paid-up capital of Rs 94.49 Cr.
The company currently has active open charges totaling ₹561.12 Cr.
The Key Managerial Personnel (KMP) at Neuberg Diagnostics Private Limited India is Thacherry Srikkanth as COMPANY SECRETARY. Sandip Shah, Gomathy Kulandaivelu, Sujay Ramaprasad, and One other member serve as directors at the Company.
- CIN/LLPIN
U85300TN2017PTC114099
- Company No.
114099
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jan 2017
- Date of AGM
27 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Saidapet, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Neuberg Diagnostics?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Thacherry Srikkanth | Company Secretary | 07-Sep-2022 | Current |
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sandip Shah | Director | 14-Jul-2023 | Current |
Gomathy Kulandaivelu | Director | 19-Oct-2017 | Current |
Sujay Ramaprasad | Director | 14-Jul-2023 | Current |
Athmanathan Ganesan | Director | 19-Oct-2017 | Current |
Financial Performance and Corporate Structure Insights of Neuberg Diagnostics.
Neuberg Diagnostics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 219.36% increase. The company also saw a substantial fall in profitability, with a 712.32% decrease in profit. The company's net worth Soared by an impressive increase of 1861.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Neuberg Diagnostics?
In 2023, Neuberg Diagnostics had a promoter holding of 100.00%. The company had 16 Subsidiaries and 4 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Neuberg Abha Laboratory Private LimitedActive 4 years 6 months
Sandip Shah, Gomathy Kulandaivelu and 1 more are mutual person
- Magnum Imaging & Diagnostics Private LimitedActive 11 years 2 months
Athmanathan Ganesan is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 28 Jul 2023 | ₹3.27 Cr | Open |
Others Creation Date: 02 Jun 2023 | ₹235.00 Cr | Open |
Hdfc Bank Limited Creation Date: 17 May 2023 | ₹4.84 Cr | Open |
How Many Employees Work at Neuberg Diagnostics?
Neuberg Diagnostics has a workforce of 957 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neuberg Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuberg Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.